Literature DB >> 25893286

Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73.

Y K Satija1, S Das1.   

Abstract

p73 is a member of the p53 tumor suppressor family, which mediates genotoxic stress response by triggering cell cycle arrest and apoptosis. Similar to p53, p73 is maintained at very low levels, but it gets rapidly induced upon genotoxic stress. Mounting evidences demonstrate that p73 is primarily regulated posttranslationally. However, the molecular mechanisms which determine its stability and activity discerningly under normal and stress conditions are still not well understood. Here, we employed a proteomics approach to identify differential interactors of p73 under normal and genotoxic stress conditions. We report here that TRIM28, an E3 ligase, interacts with p73 and targets it for proteasomal degradation under normal conditions. Genotoxic stress-induced phosphorylation of p73 at tyrosine 99 residue by c-abl kinase leads to abrogation of this interaction thereby promoting p73 stabilization. Furthermore, the phosphorylated form of p73 specifically interacts with MED15, which serves as a transcriptional coactivator and leads to activation of proarrest, proapoptotic and anti-metastatic genes. RNAi-mediated abrogation of TRIM28 expression facilitates p73-mediated tumor suppression in mouse tumor models, whereas disruption of MED15 expression abrogates p73 tumor suppressor and anti-metastatic functions. These findings provide new insights into the pivotal role of Tyr99 phosphorylation in determining p73 levels and functions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25893286     DOI: 10.1038/onc.2015.111

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

Review 1.  p73, a sophisticated p53 family member in the cancer world.

Authors:  Toshinori Ozaki; Akira Nakagawara
Journal:  Cancer Sci       Date:  2005-11       Impact factor: 6.716

2.  S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity.

Authors:  Fumiyuki Suzuki; Nobuhiko Oridate; Akihiro Homma; Yuji Nakamaru; Tatsumi Nagahashi; Katsunori Yagi; Sanae Yamaguchi; Yasushi Furuta; Satoshi Fukuda
Journal:  Oncol Rep       Date:  2005-12       Impact factor: 3.906

3.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

4.  Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.

Authors:  Noriyuki Takai; Norihiko Kawamata; Christine S Walsh; Sigal Gery; Julian C Desmond; Sadie Whittaker; Jonathan W Said; Laura M Popoviciu; Peter A Jones; Isao Miyakawa; H Phillip Koeffler
Journal:  Mol Cancer Res       Date:  2005-05       Impact factor: 5.852

5.  The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

Authors:  Sabrina Strano; Olimpia Monti; Natalia Pediconi; Alessia Baccarini; Giulia Fontemaggi; Eleonora Lapi; Fiamma Mantovani; Alexander Damalas; Gennaro Citro; Ada Sacchi; Giannino Del Sal; Massimo Levrero; Giovanni Blandino
Journal:  Mol Cell       Date:  2005-05-13       Impact factor: 17.970

6.  Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway.

Authors:  Yael Ziv; Dana Bielopolski; Yaron Galanty; Claudia Lukas; Yoichi Taya; David C Schultz; Jiri Lukas; Simon Bekker-Jensen; Jiri Bartek; Yosef Shiloh
Journal:  Nat Cell Biol       Date:  2006-07-23       Impact factor: 28.824

7.  53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair.

Authors:  Angela T Noon; Atsushi Shibata; Nicole Rief; Markus Löbrich; Grant S Stewart; Penelope A Jeggo; Aaron A Goodarzi
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

8.  Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene.

Authors:  Jingmei Zhang; Limin Liu; Gerd P Pfeifer
Journal:  Oncogene       Date:  2004-03-18       Impact factor: 9.867

Review 9.  p73: Friend or foe in tumorigenesis.

Authors:  Gerry Melino; Vincenzo De Laurenzi; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

10.  Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis.

Authors:  R Agami; G Blandino; M Oren; Y Shaul
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

View more
  5 in total

1.  The Roles of P53 and Its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis-Stage Mouse Embryos.

Authors:  Nazem El Husseini; Barbara F Hales
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

2.  PRAMEF2-mediated dynamic regulation of YAP signaling promotes tumorigenesis.

Authors:  Madhurima Ghosh; Sanjeev Das
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-30       Impact factor: 11.205

3.  p73 - NAV3 axis plays a critical role in suppression of colon cancer metastasis.

Authors:  Apoorva Uboveja; Yatendra Kumar Satija; Fouzia Siraj; Ira Sharma; Daman Saluja
Journal:  Oncogenesis       Date:  2020-02-06       Impact factor: 7.485

Review 4.  The p53 family member p73 in the regulation of cell stress response.

Authors:  Svetlana Zvereva; Aleksandra Dalina; Igor Blatov; Julian M Rozenberg; Ilya Zubarev; Daniil Luppov; Alexander Bessmertnyi; Alexander Romanishin; Lamak Alsoulaiman; Vadim Kumeiko; Alexander Kagansky; Gerry Melino; Carlo Ganini; Nikolai A Barlev
Journal:  Biol Direct       Date:  2021-11-08       Impact factor: 4.540

5.  p73-regulated FER1L4 lncRNA sponges the oncogenic potential of miR-1273g-3p and aids in the suppression of colorectal cancer metastasis.

Authors:  Apoorva Uboveja; Yatendra Kumar Satija; Fouzia Siraj; Daman Saluja
Journal:  iScience       Date:  2022-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.